We are live on ! Find out more
PAWC

P.A.W. Capital Portfolio holdings

AUM $131M
1-Year Est. Return 46.14%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$83.2M
AUM Growth
+$3.73M
Cap. Flow
+$2.22M
Cap. Flow %
2.67%
Top 10 Hldgs %
40.86%
Holding
65
New
9
Increased
10
Reduced
26
Closed
4

Top Buys

Rank Stock Value
1
EFII
Electronics for Imaging
EFII
+$2.15M
2
GAIA icon
Gaia
GAIA
+$2.1M
3
QUOT
Quotient Technology Inc
QUOT
+$886K
4
MCHX icon
Marchex
MCHX
+$646K
5
ALLT icon
Allot
ALLT
+$639K

Top Sells

Rank Stock Value
1
CCXI
ChemoCentryx, Inc.
CCXI
+$877K
2
CARB
Carbonite Inc
CARB
+$804K
3
QURE icon
uniQure
QURE
+$763K
4
CHGG icon
Chegg
CHGG
+$757K
5
CASC
Cascadian Therapeutics, Inc.
CASC
+$740K

Sector Composition

Rank Sector Weight
1 Technology 32.1%
2 Communication Services 13.33%
3 Healthcare 12.36%
4 Consumer Staples 10.53%
5 Financials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QURE icon
26
uniQure
QURE
$3.03B
$1.06M 1.27%
45,000
-35,000
-44% -$763K
CCXI
27
DELISTED
ChemoCentryx, Inc.
CCXI
$1.02M 1.23%
75,000
-85,000
-53% -$877K
WIFI
28
DELISTED
Boingo Wireless, Inc.
WIFI
$991K 1.19%
40,000
-5,000
-11% -$123K
LKFT
29
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$898K 1.08%
9,000
-3,000
-25% -$323K
RDS.A
30
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$798K 0.96%
12,500
-500
-4% -$32.9K
VZ icon
31
Verizon
VZ
$195B
$789K 0.95%
16,500
-500
-3% -$25.1K
ABT icon
32
Abbott
ABT
$183B
$719K 0.86%
12,000
– –
PFE icon
33
Pfizer
PFE
$143B
$710K 0.85%
21,080
– –
PM icon
34
Philip Morris
PM
$297B
$696K 0.84%
7,000
– –
TTE icon
35
TotalEnergies
TTE
$195B
$692K 0.83%
12,000
-2,000
-14% -$115K
OHI icon
36
Omega Healthcare
OHI
$15.1B
$676K 0.81%
25,000
-20,000
-44% -$533K
PEP icon
37
PepsiCo
PEP
$190B
$655K 0.79%
6,000
– –
MRK icon
38
Merck
MRK
$322B
$654K 0.79%
12,576
– –
KO icon
39
Coca-Cola
KO
$377B
$651K 0.78%
15,000
– –
BP icon
40
BP
BP
$116B
$649K 0.78%
17,220
-1,352
-7% -$50.9K
JNJ icon
41
Johnson & Johnson
JNJ
$618B
$641K 0.77%
5,000
– –
DD icon
42
DuPont de Nemours
DD
$18.5B
$637K 0.77%
3,949
– –
WY icon
43
Weyerhaeuser
WY
$18B
$630K 0.76%
18,000
– –
CVX icon
44
Chevron
CVX
$392B
$627K 0.75%
5,500
-500
-8% -$59.8K
GSK icon
45
GSK
GSK
$104B
$625K 0.75%
12,800
-3,200
-20% -$149K
MO icon
46
Altria Group
MO
$114B
$623K 0.75%
10,000
-1,000
-9% -$66.2K
KKR icon
47
KKR & Co
KKR
$91.1B
$609K 0.73%
30,000
– –
PG icon
48
Procter & Gamble
PG
$336B
$595K 0.71%
7,500
– –
CG icon
49
Carlyle Group
CG
$16.6B
$576K 0.69%
27,000
– –
BX icon
50
Blackstone
BX
$102B
$575K 0.69%
18,000
-2,000
-10% -$68.2K
1
2
3

Similar funds

EIM
Emmett Investment Management New York $131M AUM 25.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
LC
LTG Capital Newton, Massachusetts $131M AUM 19.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
OIM
Oder Investment Management Woodland Hills, California $130M AUM 25.54% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $130M AUM

P.A.W. Capital's Q1 2018 Portfolio in Review

As of Q1 2018, P.A.W. Capital held 65 positions worth $83.2M, up 4.7% from $79.5M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

P.A.W. Capital's Q1 2018 filing shows 9 new, 10 increased, 26 reduced and 4 closed positions. Its largest new stake was Electronics for Imaging: 75,000 shares worth $2.05M. The largest sale was ChemoCentryx, Inc., an estimated $877K.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Communication Services and Healthcare.

  • P.A.W. Capital's largest Q1 2018 buy was Electronics for Imaging: 75,000 shares worth $2.05M.
  • P.A.W. Capital added most to Quotient Technology Inc in Q1 2018, an estimated $886K increase.
  • P.A.W. Capital's biggest Q1 2018 reduction was ChemoCentryx, Inc., cutting an estimated $877K.
  • P.A.W. Capital fully exited Cascadian Therapeutics, Inc. in Q1 2018, selling an estimated $740K.
  • P.A.W. Capital's ten largest holdings make up 41% of its $83.2M portfolio in Q1 2018.
  • P.A.W. Capital opened 9 new positions and closed 4 in Q1 2018.
  • P.A.W. Capital's portfolio value rose 4.7% quarter-over-quarter to $83.2M.

Based on P.A.W. Capital's 13F filing for Q1 2018, filed 26 Apr 2018.